Role of Stress and Inflammation in the Etiology, Treatment, and Management of Premenstrual Dysphoric Disorder (PMDD)
DOI:
https://doi.org/10.46570/utjms-2026-1688Keywords:
inflammation, women's health, depression, stress, suicideAbstract
According to the DSM-5, Premenstrual Dysphoric Disorder (PMDD) is defined as a mood disorder characterized by physical, emotional, and behavioral symptoms that occur during the luteal phase and cause significant distress or impairment. While epidemiological studies highlight that PMDD occurs in 1.8-5.8% of menstruating individuals, this is a vast underestimation prevalence due in part to cultural and systematic factors that impact diagnosis. That said, it is imperative to conduct research on this debilitating condition and its impact on overall wellbeing. The objective of this review is to explore the role stress and inflammation plays on etiology, treatment, and management of PMDD. To ensure a thorough review, the inclusion criteria focused on studies published in peer reviewed journals on etiology (stress and inflammation in relation to PMDD) and the treatment and management of PMDD. Studies conducted on topics pertaining to genetics and serotonin dysregulation were not included. Additionally, research conducted prior to 2005 were also excluded from the review process. Overall, existing literature demonstrates that stress and inflammation has been found in individuals with PMDD. However, more research must be done on the potential therapeutic value of Yaz, other COCs, and anti-inflammatory agents in treatment of PMDD.
References
References
American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.). https://doi.org/10.1176/appi.books.9780890425787
Cary, E., & Simpson, P. (2024). Premenstrual disorders and PMDD - a review. Baillière’s Best Practice & Research. Clinical Endocrinology & Metabolism, 38(1), Article 101858. https://doi.org/10.1016/j.beem.2023.101858
Faucher, J., Koszycki, D., Bradwejn, J., Merali, Z., & Bielajew, C. (2016). Effects of CBT versus MBSR treatment on social stress reactions in social anxiety disorder. Mindfulness, 7(2), 514-526.
Fenton, C., Wellington, K., Moen, M. D., & Robinson, D. M. (2007). Drospirenone/Ethinylestradiol 3mg/20µg (24/4 Day Regimen) A Review of Its Use in Contraception, Premenstrual Dysphoric Disorder and Moderate Acne Vulgaris. Drugs, 67(12), 1749-1765.
Foidart, J. M., Sulak, P. J., Schellschmidt, I., Zimmermann, D., & Yasmin® Extended Regimen Study Group. (2006). The use of an oral contraceptive containing ethinylestradiol and drospirenone in an extended regimen over 126 days. Contraception, 73(1), 34-40.
Fleshner, M., Frank, M., & Maier, S. F. (2017). Danger signals and inflammasomes: stress-evoked sterile inflammation in mood disorders. Neuropsychopharmacology, 42(1), 36-45.
Gold, E. B., Wells, C., & Rasor, M. O. N. (2016). The association of inflammation with premenstrual symptoms. Journal of women's health, 25(9), 865-874.
?Liu, Y. Z., Wang, Y. X., & Jiang, C. L. (2017). Inflammation: the common pathway of stress-related diseases. Frontiers in human neuroscience, 11, 316.
Rosenblat, J. D., Cha, D. S., Mansur, R. B., & McIntyre, R. S. (2014). Inflamed moods: a review of the interactions between inflammation and mood disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 53, 23-34.
Sack, M., Lempa, W., & Lamprecht, F. (2007). Assessment of psychophysiological stress reactions during a traumatic reminder in patients treated with EMDR. Journal of EMDR Practice and Research, 1(1), 15-23.
Sangthawan, M., & Taneepanichskul, S. (2005). A comparative study of monophasic oral contraceptives containing either drospirenone 3 mg or levonorgestrel 150 ?g on premenstrual symptoms. Contraception, 71(1), 1-7.
Segerstrom, S. C., & Miller, G. E. (2004). Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychological bulletin, 130(4), 601.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Nithara Murthy, Sabrina Khuder, Manasa Swaminathan (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
